Investors - Press Releases
<< Back |
View printer-friendly version |
Neil Medical Group Selects TRHC’s DoseMeRx to Provide Precision Dosing Services For Long-term Care Facilities
“Our pharmacists are committed to applying their clinical expertise to improve health outcomes in the long-term care setting,” stated Neil Medical Group’s Senior Director of Health Outcomes and Research,
TRHC‘s DoseMeRx enables healthcare providers to optimize dosing and streamline operations, reduce adverse drug events, and decrease costs. DoseMeRx’s unique platform uses Bayesian dosing to calculate a precise dose to achieve a clinical target. In 2020, leading clinicians from the
“Advanced medication safety technology that ensures optimal patient outcomes is vital to providers in the long-term care sector,” states TRHC Chairman and CEO
Executive Vice President of TRHC’s Hospital Division,
About
Tabula Rasa HealthCare (TRHC) is a leader in providing patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize performance to improve patient outcomes, reduce hospitalizations, lower healthcare costs, and manage risk. Medication risk management is TRHC’s lead offering, and its cloud-based software applications provide solutions for a range of payers, providers, and other healthcare organizations. For more information, visit TRHC.com
About DoseMeRx
DoseMeRx® is a
About
Forward-Looking Statements
This press release includes forward-looking statements that we believe to be reasonable as of today’s date, including statements regarding Medication Risk Mitigation technology. Such statements are identified by use of the words “anticipates,” “believes,” “estimates,” “expects,” “intends,” “plans,” “predicts,” “projects,” “should,” and similar expressions. These forward-looking statements are based on management’s expectations and assumptions as of the date of this press release. Actual results might differ materially from those explicit or implicit in the forward-looking statements. Important factors that could cause actual results to differ materially include: the need to innovate and provide useful products and services; risks related to changing healthcare and other applicable regulations; increasing consolidation in the healthcare industry; managing our growth effectively; our ability to adequately protect our intellectual property; and the other risk factors set forth from time to time in our filings with the
TRHC Media Contacts abednar@trhc.com T: (856) 912-5714 dsemingson@trhc.com T: (215) 870-0829 |
TRHC Investor Contact fsparacino@trhc.com T: (866) 648-2767 |
Source: Tabula Rasa HealthCare, Inc.